The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen - PubMed (original) (raw)
. 1984 Dec;312(5994):513-6.
doi: 10.1038/312513a0.
- PMID: 6095109
- DOI: 10.1038/312513a0
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
A L Schechter et al. Nature. 1984 Dec.
Abstract
A series of rat neuro/glioblastomas all contain the same transforming gene (neu) which induces synthesis of a tumour antigen of relative molecular mass (Mr) 185,000 (p185). The neu oncogene bears homology to erb-B and the tumour antigen, p185, is serologically related to the epidermal growth factor (EGF) receptor. The two proteins, EGF receptor and p185 appear to be distinct, as they coexist in nontransformed Rat-1 cells.
Similar articles
- The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.
Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Francke U, Ullrich A, Coussens L. Schechter AL, et al. Science. 1985 Sep 6;229(4717):976-8. doi: 10.1126/science.2992090. Science. 1985. PMID: 2992090 - The neu oncogene encodes an epidermal growth factor receptor-related protein.
Bargmann CI, Hung MC, Weinberg RA. Bargmann CI, et al. Nature. 1986 Jan 16-22;319(6050):226-30. doi: 10.1038/319226a0. Nature. 1986. PMID: 3945311 - Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles.
Hung MC, Schechter AL, Chevray PY, Stern DF, Weinberg RA. Hung MC, et al. Proc Natl Acad Sci U S A. 1986 Jan;83(2):261-4. doi: 10.1073/pnas.83.2.261. Proc Natl Acad Sci U S A. 1986. PMID: 3001730 Free PMC article. - Growth factors and oncogenes in human malignant glioma.
Westermark B, Nister M, Heldin CH. Westermark B, et al. Neurol Clin. 1985 Nov;3(4):785-99. Neurol Clin. 1985. PMID: 3001490 Review. - The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.
Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Greene MI. Dougall WC, et al. Oncogene. 1994 Aug;9(8):2109-23. Oncogene. 1994. PMID: 7913542 Review.
Cited by
- scFv-based "Grababody" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors.
Cai Z, Fu T, Nagai Y, Lam L, Yee M, Zhu Z, Zhang H. Cai Z, et al. Cancer Res. 2013 Apr 15;73(8):2619-27. doi: 10.1158/0008-5472.CAN-12-3920. Epub 2013 Feb 8. Cancer Res. 2013. PMID: 23396586 Free PMC article. - Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma.
Tobi M, Kim M, Weinstein DH, Rambus MA, Hatfield J, Adsay NV, Levi E, Evans D, Lawson MJ, Fligiel S. Tobi M, et al. Dig Dis Sci. 2013 Mar;58(3):744-50. doi: 10.1007/s10620-012-2387-x. Epub 2012 Sep 22. Dig Dis Sci. 2013. PMID: 23001406 - Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cells.
Li Y, Shi L, Han C, Wang Y, Yang J, Cao C, Jiao S. Li Y, et al. Tumour Biol. 2012 Oct;33(5):1403-10. doi: 10.1007/s13277-012-0388-1. Epub 2012 Apr 14. Tumour Biol. 2012. PMID: 22528939 - Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer.
Kristeleit H, Parton M, Beresford M, Macpherson IR, Sharma R, Lazarus L, Kelleher M. Kristeleit H, et al. Target Oncol. 2016 Oct;11(5):579-591. doi: 10.1007/s11523-016-0438-5. Target Oncol. 2016. PMID: 27181019 Free PMC article. Review. - trkB, a novel tyrosine protein kinase receptor expressed during mouse neural development.
Klein R, Parada LF, Coulier F, Barbacid M. Klein R, et al. EMBO J. 1989 Dec 1;8(12):3701-9. doi: 10.1002/j.1460-2075.1989.tb08545.x. EMBO J. 1989. PMID: 2555172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous